Wobenzym 800
Combined drug. is a combination of highly active enzymes of plant and animal origin. It has an immunomodulatory, anti-inflammatory, fibrinolytic, anti-edematous, antiplatelet and secondary analgesic effect. Wobenzym has a positive effect on the course of the inflammatory process, limits the pathological manifestations of autoimmune and immunocomplex processes, and has a positive effect on the parameters of the body’s immunological reactivity. stimulates and regulates the functional activity of monocytes-macrophages, natural killers, stimulates antitumor immunity, cytotoxic T-lymphocytes, phagocytic activity of cells. Under the influence of Wobenzym, the number of circulating immune complexes decreases and membrane deposits of immune complexes are removed from tissues. Wobenzym reduces infiltration of the interstitium by plasma cells. increases the elimination of protein detritus and fibrin deposits in the area of inflammation, accelerates the lysis of toxic metabolic products and dying tissues, improves the resorption of hematomas and edema, normalizes the permeability of vessel walls. Wobenzym reduces the concentration of thromboxane and platelet aggregation. regulates the adhesion of blood cells, increases the ability of erythrocytes to change their shape by regulating their plasticity, normalizes the number of normal discocytes (platelets) and reduces the total number of activated forms of platelets, normalizes blood viscosity, reduces the total number of microaggregants, thus improving microcirculation and rheological properties of blood, and also supply tissues with oxygen and nutrients. Wobenzym normalizes lipid metabolism, reduces the synthesis of endogenous cholesterol, increases HDL content, reduces the level of atherogenic lipids, improves the absorption of polyunsaturated fatty acids. Wobenzym increases the effectiveness of antibiotic therapy by increasing the concentration of antibiotics in the blood plasma and inflammation, as well as reduces the side effects of antibiotics (dysbacteriosis). Wobenzym reduces the severity of side effects associated with taking hormonal drugs (including hypercoagulation). Wobenzym regulates nonspecific defense mechanisms (production of interferons), t thereby exhibiting antiviral and antimicrobial activity.
Indications for use
Rheumatoid arthritis, non-articular rheumatism, osteoarthritis, Bechterew’s disease, Sjögren’s disease, injuries (fractures, bruises, distortions, dislocations, contusions), inflammation of soft tissues, chronic post-traumatic processes, injuries in sports medicine, post-traumatic edema, sinusitis, bronchitis, bronchopneumonia, pancreatitis, ulcerative colitis, Crohn’s disease, multiple sclerosis, ischemic heart disease, myocardial infarction, secondary prevention of recurrent myocardial infarction, thrombophlebitis, post-thrombotic syndrome, vasculitis, thromboangiitis obliterans, prevention of recurrent phlebitis, lymphedema, secondary lymphedema, inflammation of the urinary tract (cystitis , cystopyelitis, prostatitis), chronic infections in gynecology, adnexitis, mastopathy.
Contraindications
Individual hypersensitivity to the components of the drug. Severe congenital or acquired bleeding disorders (hemophilia, severe liver damage), diseases associated with an increased likelihood of bleeding, thrombocytopenia.
Use during pregnancy and during breastfeeding
With caution and under the supervision of a physician, Wobenzym should be prescribed during pregnancy and lactation.
Dosage and administration
inside. Tablets are recommended to be taken at least 30 minutes before meals, without chewing, drinking plenty of water (200 ml). The course dose of the drug is selected individually.
